F. McTaggart

发表

Phenotype-dependent and -independent actions of rosuvastatin on atherogenic lipoprotein subfractions in hyperlipidaemia.

C. Packard, M. Caslake, P. Laggner, 2003, Atherosclerosis.

Comparison of the effects of high doses of rosuvastatin versus atorvastatin on the subpopulations of high-density lipoproteins.

E. Schaefer, E. Stein, B. Asztalos, 2007, The American journal of cardiology.

On the Selection of Animal Species as Models for Atherosclerosis Research, with Particular Reference to the Common Marmoset (Callithrix Jacchus)

P. Forgez, S. Goldstein, M. Chapman, 1982 .

Novel optimised quinuclidine squalene synthase inhibitors

G. R. Brown, A. Foubister, F. McTaggart, 1997 .

Impact of the bowel‐screening programme on the diagnosis of colorectal cancer in Ayrshire and Arran

M. Balsitis, R. Diament, C. Roxburgh, 2013, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

Oxidized low-density lipoproteins inhibit endothelium-dependent relaxations in isolated large and small rabbit coronary arteries.

K. Bruckdorfer, F. McTaggart, M. Jacobs, 1996, Journal of autonomic pharmacology.

Relationship between plasma high-density lipoprotein concentrations and lipoprotein lipase and hepatic lipase activities in children with hyperlipidaemia.

D. Muller, F. McTaggart, E. Layward, 1981, Clinical science.

Uptake of HMG-CoA reductase inhibitor ZD4522 into hepatocytes and distribution into liver and other tissues of the rat

H. Hasegawa, K. Higaki, K. Nezasa, 2000 .

Pharmacological properties of ZD4522 — A new HMG-CoA reductase inhibitor

R. Davidson, N. Torr, W. Ward, 2000 .

Optimizing the pharmacology of statins: characteristics of rosuvastatin.

M. Chapman, F. McTaggart, 2002, Atherosclerosis. Supplements.

Comparative pharmacology of rosuvastatin.

F. McTaggart, 2003, Atherosclerosis. Supplements.

Inhibition of squalene synthase of rat liver by novel 3' substituted quinuclidines.

G. Smith, R. Davidson, G. R. Brown, 1996, Biochemical pharmacology.

Effect of short-term rosuvastatin treatment on estimated glomerular filtration rate.

P. Sager, J. Sorof, D. Vidt, 2006, The American journal of cardiology.

Some effects of diet on guinea pig serum lipoproteins.

M. Chapman, G. Mills, F. McTaggart, 1972, Biochimica et biophysica acta.

Synthesis and activity of a novel series of 3-biarylquinuclidine squalene synthase inhibitors.

M. Taylor, G. Smith, G. R. Brown, 1996, Journal of medicinal chemistry.

A novel series of 4-piperidinopyridine and 4-piperidinopyrimidine inhibitors of 2,3-oxidosqualene cyclase-lanosterol synthase.

G. Smith, S. Glossop, G. R. Brown, 2000, Journal of medicinal chemistry.

Molecular mechanism for inhibition of 3-hydroxy-3-methylglutaryl CoA (HMG-CoA) reductase by rosuvastatin.

G. Holdgate, W. Ward, F. McTaggart, 2003, Biochemical Society transactions.

Inhibitors of 3-hydroxy-3-methylglutaryl-CoA reductase reduce receptor-mediated endocytosis in opossum kidney cells.

J. Sidaway, T. Orton, N. Brunskill, 2004, Journal of the American Society of Nephrology : JASN.

Effects of Statins on High-Density Lipoproteins: A Potential Contribution to Cardiovascular Benefit

P. Jones, F. McTaggart, Peter H. Jones, 2008, Cardiovascular Drugs and Therapy.

Lipoprotein Fractions and Antithrombin III Consumption During Clotting

B. Bennett, F. McTaggart, A. Douglas, 1982, Thrombosis and Haemostasis.

Preclinical and clinical pharmacology of Rosuvastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor.

R. Davidson, G. Holdgate, A. McCormick, 2001, The American journal of cardiology.

Inhibition of squalene synthase in vitro by 3-(biphenyl-4-yl)-quinuclidine.

R. Davidson, G. R. Brown, M. Eakin, 1996, Biochemical pharmacology.

Quinuclidine inhibitors of 2,3-oxidosqualene cyclase-lanosterol synthase: optimization from lipid profiles.

G. Smith, S. Glossop, G. R. Brown, 1999, Journal of medicinal chemistry.

Rosuvastatin: a highly effective new HMG-CoA reductase inhibitor.

A. Olsson, A. Raza, F. McTaggart, 2006, Cardiovascular drug reviews.

New dimension of statin action on apoB atherogenicity

C. Packard, M. Caslake, M. Chapman, 2003, Clinical cardiology.

Selectivity of ZD4522 for inhibition of cholesterol synthesis in hepatic versus non-hepatic cells

R. Davidson, C. Dunkley, J. Stafford, 2000 .

Kinetics of inhibition of HMG-CoA reductase by a new statin, rosuvastatin

R. Davidson, G. Holdgate, W. Ward, 2001 .

3P-0786 Rosuvastatin: Kinetics of apoB-containing lipoproteins in moderate hypercholesterolemia

C. Packard, M. Caslake, N. Joss, 2003 .

Effects of rosuvastatin, a new HMG-CoA reductase inhibitor, on neurovascular function in diabetic rats

Gj Smith, M. Inkster, M. Cotter, 2001 .

Comparison of guinea-pig serum lipoproteins after iodination by two different methods.

G. Mills, P. Weech, F. McTaggart, 1978, Biochemical Journal.

Density distribution, characterization, and comparative aspects of the major serum lipoproteins in the common marmoset (Callithrix jacchus), a New World primate with potential use in lipoprotein research.

S. Goldstein, M. Chapman, F. McTaggart, 1979, Biochemistry.